Terms: = Ovarian cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Diagnosis
4884 results:
1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
2. Circular RNA circMAN1A2 promotes ovarian cancer progression through the microRNA-135a-3p/IL1RAP/TAK1 pathway.
Li B; Hu C; Zhao D; Nie M; Wang X
PeerJ; 2024; 12():e16967. PubMed ID: 38680890
[TBL] [Abstract] [Full Text] [Related]
3. Cardiovascular mortality risk in patients with ovarian cancer: a population-based study.
Hu ZL; Yuan YX; Xia MY; Li Y; Yang Y; Wang SN; Meng XZ; Sun MY; Wang N
J Ovarian Res; 2024 Apr; 17(1):88. PubMed ID: 38664732
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or ovarian cancer.
Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
[TBL] [Abstract] [Full Text] [Related]
5. Granulosa cell tumor of the ovary: a series of 6 cases.
da Costa REAR; Silva MCA; Cavalcante ECX; Branco ROC; Dos Reis CA; Vieira SC
Pan Afr Med J; 2024; 47():58. PubMed ID: 38646138
[TBL] [Abstract] [Full Text] [Related]
6. Imaging for local recurrence of breast cancer.
Schlaiss T; Bott L; Herbert SL; Bartmann C; Kiesel M; Salmen J; Sauer ST; Christner SA; Petritsch B; Grunz JP; Woeckel A; Löb S; Diessner J
J Cancer Res Clin Oncol; 2024 Apr; 150(4):200. PubMed ID: 38627285
[TBL] [Abstract] [Full Text] [Related]
7. Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancer.
Kallio HM; Savolainen K; Virtanen T; Ryyppö L; Selin H; Martikainen P; Staff S; Kivinummi K; Sipola J; Vuorinen J; Nikkola J; Nykter M; Auranen A; Annala M
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38580393
[TBL] [Abstract] [Full Text] [Related]
8. [Non-primary solid malignancies of breast in needle core biopsy: a clinicopathological analysis of 23 cases].
Gu WQ; Wang L; Xu JC; Ping GQ; Han X; Wang C
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):331-336. PubMed ID: 38556815
[No Abstract] [Full Text] [Related]
9. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
12. A Survival Analysis of Patients with Recurrent Epithelial ovarian cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia.
Harutyunyan L; Manvelyan E; Karapetyan N; Bardakhchyan S; Jilavyan A; Tamamyan G; Avagyan A; Safaryan L; Zohrabyan D; Movsisyan N; Avinyan A; Galoyan A; Sargsyan M; Harutyunyan M; Nersoyan H; Stepanyan A; Galstyan A; Danielyan S; Muradyan A; Jilavyan G
Curr Oncol; 2024 Mar; 31(3):1323-1334. PubMed ID: 38534933
[TBL] [Abstract] [Full Text] [Related]
13. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
Alwafai Z; Beck MH; Fazeli S; Gürtler K; Kunz C; Singhartinger J; Trojnarska D; Zocholl D; Krankenberg DJ; Blohmer JU; Sehouli J; Pietzner K
BMC Cancer; 2024 Mar; 24(1):380. PubMed ID: 38528468
[TBL] [Abstract] [Full Text] [Related]
14. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
15. A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device.
Natarajan P; Martha Schofield A; Elena Vinturache A; Ruthven S; Lane S; Duncan Macdonald R
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():311-315. PubMed ID: 38518485
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
[TBL] [Abstract] [Full Text] [Related]
17. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
18. diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
[TBL] [Abstract] [Full Text] [Related]
19. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.
Trama A; Botta L; Stiller C; Visser O; Cañete-Nieto A; Spycher B; Bielska-Lasota M; Katalinic A; Vener C; Innos K; Marcos-Gragera R; Paapsi K; Guevara M; Demuru E; Mousavi SM; Blum M; Eberle A; Ferrari A; Bernasconi A; Lasalvia P;
Eur J Cancer; 2024 May; 202():113558. PubMed ID: 38489859
[TBL] [Abstract] [Full Text] [Related]
20. ovarian cancer is detectable from peripheral blood using machine learning over T-cell receptor repertoires.
Zuckerbrot-Schuldenfrei M; Aviel-Ronen S; Zilberberg A; Efroni S
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38483254
[TBL] [Abstract] [Full Text] [Related]
[Next]